-
Taxonomy & unit
-
ratio: %
-
Description
-
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
-
Summary
-
Cyclacel Pharmaceuticals, Inc. quarterly/annual Return On Assets history and growth rate from 2012 to 2023.
- Cyclacel Pharmaceuticals, Inc. Return On Assets for the quarter ending June 30, 2024 was -196 %, a 105% decline year-over-year.
- Cyclacel Pharmaceuticals, Inc. annual Return On Assets for 2023 was -148 %, a 137% decline from 2022.
- Cyclacel Pharmaceuticals, Inc. annual Return On Assets for 2022 was -62.5 %, a 57.9% decline from 2021.
- Cyclacel Pharmaceuticals, Inc. annual Return On Assets for 2021 was -39.6 %, a 24.4% decline from 2020.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)